Vitamin e and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamin e (tocopherols and tocotrienols) and Ocrevus (ocrelizumab). Common drug interactions include globulins decreased among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Vitamin e and Ocrevus. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamin e?

Vitamin e has active ingredients of tocopherols and tocotrienols. It is often used in vitamin supplementation. eHealthMe is studying from 42,279 Vitamin e users. Check the latest studies of Vitamin e.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

On Jul, 14, 2026

62 people who take Vitamin e and Ocrevus together, and have interactions are studied.

Vitamin e and Ocrevus drug interactions.

What are the common drug interactions of Vitamin E and Ocrevus, by gender? *:

female:

Globulins decreased
Herpes zoster
Ill-defined disorder
Immunodeficiency
Insomnia (sleeplessness)
Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
Muscle spasms (muscle contraction)
Muscular weakness (muscle weakness)
Oropharyngeal pain
Rhinorrhoea (watery mucus discharge from the nose)

male:

Asthenia (weakness)
Fall
Constipation
Dehydration (dryness resulting from the removal of water)
Feeding disorder (when children refuse to eat certain food groups)
Joint range of motion decreased (disease of joint movement)
Tremor (trembling or shaking movements in one or more parts of your body)
Urinary tract infection
Visual impairment
Balance disorder

What are the common drug interactions of Vitamin E and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Back pain
Ephelides (tanned macules found on the skin)
Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))

40-49:

Balance disorder
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Cough
Pain
Muscular weakness (muscle weakness)
Urinary tract infection
Visual impairment
Crepitations (noises are produced by the rubbing of parts one against the other)
Dysphonia (speech disorder attributable to a disorder of phonation)
Fall

50-59:

Throat irritation
Abdominal distension
Abdominal pain
Abnormal faeces (abnormal stool)
Asthenia (weakness)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Cerebral disorder (brain disease)
Decreased appetite
Depression
Device occlusion

60+:

Asthenia (weakness)
Fall
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Pain
Abdominal pain upper
Allergy to chemicals
Back pain
Balance disorder
Chills (felling of cold)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 33 people, 53.23%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 16 people, 25.81%
Stress And Anxiety: 7 people, 11.29%
Pain: 6 people, 9.68%
Gait Disturbance: 6 people, 9.68%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 8.06%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 6.45%
Muscle Spasms (muscle contraction): 4 people, 6.45%
Depression: 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamin e and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously